documents: FDA-2018-N-1262-0024

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2018-N-1262-0024 FDA FDA-2018-N-1262 Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; TREMFYA (guselkumab) Notice Announcement 2024-10-11T04:00:00Z 2024 10 2024-10-11T04:00:00Z   2024-10-11T14:35:40Z 2024-23629 0 0 09000064867c9627

Links from other tables